Sunday November 19th 2017

Mycophenolate mofetil in multiple sclerosis: a multicentre retrospective study on 344 patients

Objectives Mycophenolate mofetil (MMF) is an immunosuppressive agent, sometimes used as a disease-modifying therapy for multiple sclerosis (MS). Several studies have reported the relative safety of this treatment but, to date, its efficacy has rarely been described. We performed a retrospective study to assess the safety and efficacy of MMF in patients with MS. Methodology Three French MS centres included all of their patients treated by MMF. The main outcome criterion was annualised relapse rate (ARR) in the 1 year period after onset of MMF compared with the 1 year control period. Treatment with another immunosuppressive drug, such as mitoxantrone or cyclophosphamide, in the 2 years preceding initiation of MMF was included in a subgroup analysis. MMF safety and progression of the Ex…

MedWorm Sponsor Message: Find the best Christmas Sales, Boxing Day Sales and January Sales here.

Jump to original: 

Mycophenolate mofetil in multiple sclerosis: a multicentre retrospective study on 344 patients

Leave a Comment

More from category

Gut bacteria at young age can contribute to MS disease onset and progression, study suggests
Gut bacteria at young age can contribute to MS disease onset and progression, study suggests

Researchers at Rutgers Robert Wood Johnson Medical School published a study suggesting that gut bacteria at young age [Read More]

Age and gut bacteria contribute to MS disease progression, according to Rutgers
Age and gut bacteria contribute to MS disease progression, according to Rutgers

(Rutgers University) Gut bacteria at a young age can contribute to multiple sclerosis disease onset and progression. [Read More]

Virtual reality training may be effective alternative to standard therapy after stroke
Virtual reality training may be effective alternative to standard therapy after stroke

Using virtual reality therapy to improve arm and hand movement after a stroke is equally as effective as regular [Read More]

Social care failing people with disabilities, says leading charity
Social care failing people with disabilities, says leading charity

Young people with MS forced to live in care homes for older people Related items fromOnMedica Social care set to eat up [Read More]

World’s Largest MS Research Conference Features Advances in Progressive MS, Myelin Repair, Lifestyle
World’s Largest MS Research Conference Features Advances in Progressive MS, Myelin Repair, Lifestyle

/About-the-Society/News/World’s-Largest-MS-Research-Conference-Features-Ad [Read More]